Inventor
Carol Bachand
Inventor
Candiac, CA
Overview
Patents· 31 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07HSugars5%
PatentTitleYear
9,758,487'Hepatitis C virus inhibitors'20179,227,961'Hepatitis C virus inhibitors'20169,018,390'Hepatitis C virus inhibitors'20158,846,023'Hepatitis C virus inhibitors'20148,642,025'Hepatitis C virus inhibitors'20148,574,563'Hepatitis C virus inhibitors'20138,492,553'Hepatitis C virus inhibitors'20138,303,944'Hepatitis C virus inhibitors'20128,288,562'Hepatitis C virus inhibitors'20128,147,818'Hepatitis C virus inhibitors'20128,143,414'Hepatitis C virus inhibitors'20128,093,243'Hepatitis C virus inhibitors'20127,915,283'Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides'20117,759,495'Hepatitis C virus inhibitors'20107,745,636'Hepatitis C virus inhibitors'20107,741,347'Hepatitis C virus inhibitors'20107,704,992'Hepatitis C virus inhibitors'20107,659,270'Hepatitis C virus inhibitors'20107,501,419'4-Squarylpiperazine derivatives as antiviral agents'20097,348,337'Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides'20087,138,377'Topoisomerase inhibitors'20066,855,698'Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles'20056,677,450'Topoisomerase inhibitors'20046,653,290'Tumor proliferation inhibitors'20035,672,701'4-substituted alkyl carbapenem antibiotics'19975,116,833'Antibiotic C-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof'19924,665,169'Carbapenem antibiotics'19874,202,982'Process for the preparation of 14-hydroxymorphinan derivatives'19804,153,603'(.+-.)-2-Cyclobutylmethyl-9.alpha.,10.beta.-dihydroxy-1.beta.-(p-alkox y-benzyl)perhydroisoquinoline'19794,058,531'Process for the preparation of 14-hydroxymorphinan derivatives'19774,052,389'Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one'1977Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1977–1980Based in Cote Ste-Catherine, CA· patent location history
1987–2017Based in Candiac, CA· patent location history
1992–2017Patents assigned to BRISTOL MYERS SQUIBB CO (26)· patent assignee history
2012–2013Patents assigned to BACHAND CAROL (7)· patent assignee history
2012–2013Patents assigned to LAVOIE RICO (7)· patent assignee history
2012–2013Patents assigned to RUEDIGER EDWARD H (7)· patent assignee history
2012–2013Patents assigned to BELEMA MAKONEN (6)· patent assignee history
2016Based in Quebec, CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 26 | 1992–2017 |
| BACHAND CAROLself | 7 | 2012–2013 |
| LAVOIE RICO | 7 | 2012–2013 |
| RUEDIGER EDWARD H | 7 | 2012–2013 |
| BELEMA MAKONEN | 6 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Candiac, CA | 26 | 1987–2017 |
| Cote Ste-Catherine, CA | 4 | 1977–1980 |
| Quebec, CA | 1 | 2016 |